Fig. 8From: Development and validation of prognostic markers in sarcomas base on a multi-omics analysisa The top 50 mutated genes between iC subtypes. b The number of mutations of the top 50 genes in the iC subtype. c Distribution of silent, nonsilent and neoantigens on iC subtypes. d Distribution of CNV Gain/Loss and methylated MetHyper/MetHypo on iC subtypesBack to article page